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Introduction
 
 
 
In order to understand how cells regulate endocytosis and intracellular transport 
routes, to gain knowledge about the proteins involved and their specific functions, it 
is important to define suitable model systems. Protein toxins have proven to be 
powerful tools to study the endocytic pathway, and important knowledge has been 
acquired due to these studies. 
 
Protein toxins 
Protein toxins are perhaps most known for 
the diseases they cause in humans, such as 
diphtheria, cholera and tetanus. But these 
molecules can paradoxically be used to our 
benefit (Box 1), and have turned out to 
become invaluable tools for the studies of 
intracellular trafficking (Schiavo and van 
der Goot, 2001; Sandvig and van Deurs, 
2002). This is due to the long journey 
some of these toxins make inside cells in 
order to reach their final destination and 
eventually kill the cell. 
 One class of protein toxins, the AB-
family, comprises both plant and bacterial 
toxins that share an overall structural 
organization. These proteins consist of an 
enzymatically active A-moiety, responsible 
for their toxic effect, and a cell binding B-
moiety. The receptors for the B-moieties 
differ from one toxin to another. However, 
the toxins share the need to enter the 
cytosol in order to exert their toxicity. 
After binding to the cell surface, the toxin 
is endocytosed. The variety of endocytic 
pathways present in cells has partly been 
revealed through studies of protein toxins, 
which seem to exploit them all to their 
advantage (Sandvig et al., 2002; Conner 
and Schmid, 2003). After endocytosis, the 
toxin can be transported by several 
different pathways (Fig. 2). In some cases, 
most of it is actually recycled back to the 
cell surface, meaning that it will not harm 
the cell. Another part will be degraded in 
the lysosomes, while only very little of the 
toxin is transported to the appropriate 
compartment from which it enters the 
cytosol. For some bacterial toxins, such as 
diphtheria toxin and anthrax toxin, 
translocation takes place when the toxin 
reaches endosomes with low pH (Sandvig 
and van Deurs, 2005). Shiga toxin and the 
plant toxin ricin, however, are transported 
via the Golgi apparatus all the way to the 
endoplasmic reticulum (ER) before 
translocation to the cytosol occurs 
(Sandvig et al., 2005).  
What is the purpose of this 
extensive voyage? There are several points 
to consider. To start with, some toxins are 
activated by proteases they meet on their 
way to the ER. Shiga toxin, for instance, is 
cleaved and thereby activated by furin, an 
enzyme that recycles between the plasma 
membrane and the Golgi apparatus (Garred 
et al., 1995).  Furthermore, the ER 
membrane is probably more permeable 
than the plasma membrane or the 
endosomal membrane due to its low 
cholesterol content. Also, protein 
translocons and chaperones are present in 
the ER, and some of these have been 
shown to play a role in toxin 
retrotranslocation (Schmitz et al., 2000; 
Tsai et al., 2001; Yu and Haslam, 2005; 
Slominska-Wojewodzka et al., 2006). 
The patient work of establishing the 
cellular pathways used by toxins has been 
fruitful. Important understanding of protein 
transport has been acquired (Sandvig et al., 
1992; Sandvig et al., 2002). Furthermore, 
these toxins are now being used as tools 
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for further investigations of molecular 
mechanisms involved in their proper 
trafficking. 
Ricin 
Ricin is found in the seeds of the castor 
bean plant Ricinus communis. It consists of 
one A-moiety and one B-moiety, held 
together by a disulfide bridge (Fig. 1). The 
B-moiety is a lectin, and binds to the cell 
surface via glycoproteins and glycolipids 
with a terminal galactose. 
The A-moiety acts by removing a 
single adenine residue from an exposed 
loop of the 28S ribosomal RNA (for 
review see (Olsnes and Kozlov, 2001)). 
This loop is involved in binding of 
elongation factors, and the modified 
ribosomes are therefore no longer able to 
support protein synthesis. Due to its 
catalytic activity, one toxin molecule is 
sufficient to inactivate a few thousand 
ribosomes per minute (Olsnes et al., 1975). 
Thus, a single ricin molecule can be lethal 
to the target cell. 
 
Shiga toxin 
Shiga toxin is produced by the bacterium 
Shigella dysenteriae. It consists of one A-
moiety linked to a pentamer of identical B-
subunits (Fig. 1). The A-moiety consists of 
an A1 and A2 fragment, held together by a 
disulfide bond and the sequence that is 
cleaved by furin. Shiga toxin, like ricin, 
acts by inactivating ribosomes, and it is the 
A1 fragment that is responsible for its toxic 
effect. 
 The B-moiety binds to the 
glycolipid Gb3 at the cell surface. Unlike 
ricin, Shiga toxin acts only on a limited 
number of cell types (Paton et al., 1998). 
This is partly due to lack of receptor, but 
even when the toxin binds to the cell, this 
cell might be resistant. This can be 
explained by lack of transport to the Golgi 
apparatus and the ER (Sandvig and van 
Deurs, 1996). 
 
 
 
 
 
 
 
The endocytic pathway 
Eukaryotic cells have developed several 
pathways in order to internalize material 
from the extracellular milieu and transport 
it to its proper destination inside the cell. 
Internalized proteins will generally be 
delivered to early endosomes first. From 
this compartment, they will either be 
recycled back to the cell surface, or sent to 
lysosomes for degradation. In other cases, 
the protein is sorted retrogradely to the 
Golgi apparatus (Fig. 2).  
In our studies, we have mainly 
investigated the retrograde pathway used 
by protein toxins, and this will therefore be 
the focus of the following sections. 
 
Endocytosis 
The process by which cells internalize 
proteins together with patches of their 
plasma membrane is called endocytosis. 
Several forms of endocytosis exist. 
Phagocytosis (literally, cell-eating) 
is used to internalize large particles such as 
bacteria, while macropinocytosis (literally, 
cell-drinking) is used to internalize large 
amounts of fluid (Fig. 3) (Cardelli, 2001). 
The vesicles formed by these types of 
endocytosis are large compared to other 
forms of endocytosis (>0.5-1 m in 
Figure 1: Structures of ricin and Shiga toxin 
Ricin (left) consists of a cell-binding B-moiety 
(blue) coupled to a toxic A-moiety (orange) (PDB 
protein data bank; 2aai). Shiga toxin (right) is 
made up of five identical B-subunits (bottom) 
coupled to an A-moiety (top) (PDB protein data 
bank; 1dm0).
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diameter). This is due to large scale actin-
mediated remodelling of the plasma 
membrane (Fig. 3). Among the many 
receptor-mediated endocytic pathways, 
clathrin-dependent endocytosis 
constitutes a major route for selective 
receptor internalization in higher 
eukaryotes (Fig. 3). The vesicle formation 
begins with recruitment of clathrin, 
adaptors and endocytic accessory proteins 
to the plasma membrane, where they form 
patches ranging in diameter from 10 to 
more than 50 nm (Heuser, 1980). By the 
use of electron microscopy, stunning 
images of the clathrin network at various 
stages of invagination have emerged 
(Heuser, 1980). The network starts out as 
mainly hexagonal, with the presence of 
pentagons increasing with the degree of 
curvature (Heuser, 1980). The large 
GTPase dynamin is then rapidly recruited 
to the neck of the vesicle, probably through 
curvature-sensing proteins. In addition to 
dynamin, several other proteins mediate 
scission of the vesicle (Ungewickell and 
Hinrichsen, 2007). After vesicle 
internalization, the clathrin coat is released. 
A second endocytic pathway that 
takes advantage of a coat protein is 
caveolin-dependent endocytosis (Fig. 3). 
Caveolae are commonly referred to as 
flask-shaped invaginations in the plasma 
membrane, but their morphology may vary 
(Richter et al., 2008). In fact, they got their 
name because they resembled little caves 
when they were observed in the gall 
bladder epithelium (Yamada, 1955). 
Caveolae are 50-80 nm in diameter, and 
enriched in caveolins, sphingolipids and 
cholesterol (Thomas and Smart, 2008). 
However, caveolae are mostly stable 
structures at the plasma membrane, but can 
be induced to pinch off (Hommelgaard et 
al., 2005).  
In addition to these pathways, 
several clathrin- and caveolin-
independent pathways exist. These can 
roughly be distinguished according to their  
 
 
 
 
 
 
 
 
 
dynamin dependency and the type of small 
GTP binding protein involved (Mayor et 
al., 2007) (Fig. 3). One protein 
determinant of the dynamin independent 
pathway was recently shown to be flotillin-
1 (Glebov et al., 2006). 
Whereas Shiga toxin, at least in 
some cell types, is internalized mainly via 
clathrin-coated pits (Sandvig et al., 1989; 
Sandvig et al., 1991), ricin can use both 
clathrin-dependent and clathrin–
independent pathways for its entry (Moya 
et al., 1985; van Deurs et al., 1989; 
Sandvig and van Deurs, 1991). 
Interestingly, though, Shiga toxin was 
recently shown to be able to induce 
clathrin independent membrane 
invaginations (Romer et al., 2007).  
 
Endosome to Golgi transport  
From early endosomes, protein toxins can 
be recycled, sent to lysosomes for 
degradation, or sorted to the Golgi 
apparatus (Fig. 2). Although crucial for its 
Figure 2: Intracellular pathways 
After internalization, proteins can be sorted into 
different pathways. EE; early endosome, LE; late 
endosome, MVB; multivesicular body, TGN; 
trans-Golgi network, ER; endoplasmic reticulum. 
Mechanisms in intracellular transport of toxins 
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intoxication, less than 5% of the 
endocytosed ricin has been estimated to 
reach the trans-Golgi network (TGN) (van 
Deurs et al., 1988). A well described 
transport route leading from early 
endosomes to the Golgi apparatus goes via 
late endosomes in a Rab9 dependent 
manner (Lombardi et al., 1993; Riederer et 
al., 1994). However, ricin is transported 
independently of Rab9, suggesting that it 
circumvents the late endosomes (Iversen et 
al., 2001). Also Shiga toxin is transported 
directly from early endosomes to the Golgi 
apparatus (Mallard et al., 1998). 
 Retromer is a protein complex 
involved in endosome to Golgi transport, 
first identified in yeast (Seaman et al., 
1998). It consists of five proteins, where 
Vps5p and Vps17p form a heterodimer 
which associates with a complex of 
Vps26p, Vps29p and Vps35p. SNX1 and 
SNX2 are the human orthologs of Vps5p. 
SNX1 is an accepted retromer component 
(Haft et al., 2000; Gullapalli et al., 2004), 
while the role of SNX2 is still debated 
(Haft et al., 2000; Griffin et al., 2005; 
Carlton et al., 2005; Rojas et al., 2006). 
The retromer subunits Vps26 and SNX1, 
as well as SNX2, have been shown to 
mediate endosome to Golgi transport of 
Shiga toxin (Popoff et al., 2007; Bujny et 
al., 2007; Utskarpen et al., 2007). The role 
of retromer in ricin transport has not yet 
been fully investigated. But it is clear that 
SNX1 is not required for its normal 
transport, whereas SNX2 is (Paper I). 
SNX4, a protein first shown to mediate a 
pathway different from the retromer 
pathway in yeast (Hettema et al., 2003), is 
also involved in endosome to Golgi 
transport of ricin (Paper I).  
The cytoskeleton seems to be of 
importance for retrograde transport. 
Microtubules and the motor protein dynein 
have been shown to mediate endosome to 
Golgi transport of the mannose 6-
phosphate receptor and of Shiga toxin (Itin 
et al., 1999; Hehnly et al., 2006). 
Interestingly, Shiga toxin induces 
microtubuli assembly (Takenouchi et al., 
2004; Hehnly et al., 2006), and thus seems 
to regulate its own transport. This view is 
in agreement with reports of Shiga induced 
signalling which leads to enhanced Shiga 
transport (Lauvrak et al., 2006)(Paper II).  
Microtubules and dynein appear to play a 
role also in ricin transport (Paper III). 
Dynein is found in complex with SNX4, 
and seems to mediate SNX4 positive 
vesicle movement (Traer et al., 
2007)(Paper III).  
Translocation from ER to cytosol 
From the Golgi apparatus, the transport 
continues all the way to the ER. Some 
members of the AB-family of toxins, such 
as cholera toxin, heat-labile enterotoxin 
and Pseudomonas aeruginosa exotoxin A 
(ExoA), have a C-terminal ER-retrieval 
signal; a KDEL or related tetrapeptide. 
Soluble proteins with such a signal can be 
transported from the Golgi to the ER by 
the KDEL receptor (Pelham, 1996). While 
the ER-retention sequence is required for 
Figure 3: Endocytic pathways 
Large particles are internalized by 
phagocytosis, whereas liquid is taken up 
by pinocytosis. Most internalized 
material is delivered to early endosomes 
via vesicular (clathrin- or caveolin-
coated vesicles) or tubular intermediates 
(clathrin- and dynamin-independent 
carriers; CLICs). Other intermediate 
compartments are the caveosomes and 
glycosyl phosphatidylinositol-anchored 
protein enriched early endosomal 
compartments (GEEC). Adapted from 
(Mayor and Pagano, 2007). 
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ExoA toxicity (Chaudhary et al., 1990), it 
rather enhances the transport of cholera 
toxin and heat-labile enterotoxin (Lencer et 
al., 1995). It is not clear how toxins 
without an ER-retention sequence reach 
the ER. Still, Shiga toxin has been 
visualized in the ER using electron 
microscopy (Sandvig et al., 1992; Sandvig 
et al., 1994), and transport of ricin to the 
ER has been established (Rapak et al., 
1997). 
 When the toxins have reached the 
ER, they become processed into their 
respective A and B subunits (Ogata et al., 
1990; Hazes et al., 1996; Tsai et al., 2001; 
Rodighiero et al., 2002; Spooner et al., 
2004). For both ricin and cholera toxin, the 
A chain is released from the holotoxin and 
unfolded in the lumen of the ER by the 
chaperone protein disulfide isomerase 
(PDI) (Tsai et al., 2001; Spooner et al., 
2004). Eventually, the toxins are 
translocated to the cytosol where they exert 
their toxic effect. Accumulating evidence 
suggest that they take advantage of the ER-
associated degradation pathway (ERAD), 
which normally removes misfolded or 
unassembled proteins from the ER (Lord et 
Box 1 Toxins in disease and health
 
Protein toxins are the cause of several known diseases in human. Cholera toxin produced by the 
bacterium Vibrio cholerae is responsible for the massive diarrhea seen in Asiatic cholera (Lencer, 
2001). Every year, 5 million people catch the disease in Asia and Africa. In its most severe forms, 
cholera is one of the most rapidly fatal illnesses known. A previously healthy person may die 
within hours of onset (Lencer, 2001). 
Shiga toxin-producing Escherichia coli (STEC) strains have emerged as a significant 
cause of human gastrointestinal disease, which may result in life-threatening complications such 
as haemolytic-uremic syndrome. Food-borne outbreaks of STEC disease seem to be increasing, 
and may involve large numbers of people when food is mass-produced and mass-distributed 
(Paton and Paton, 1998). 
Diphtheria is caused by diphtheria toxin, a third member of the AB-toxins. Symptoms 
include fatigue, fever, sore throat and difficulties with swallowing. The disease was previously 
quite common, but has largely been eradicated in developed countries due to widespread 
vaccination. 
When it was discovered that some toxins consist of two distinct parts with different 
functions, the idea of using them for targeted cell killing arose. Immunotoxins were originally 
generated by coupling a protein toxin, or only its enzymatic moiety, to an antibody. Other 
immunologic proteins such as growth factors and cytokines have later been conjugated to toxins, 
and therefore a wider definition of immunotoxins has been proposed to include protein toxins 
connected to a cell binding ligand of immunologic interest (Kreitman, 2006). The goal is clear - 
targeted cancer therapy (Pastan et al., 2007). Denileukin diftitox is an example of a promising 
immunotoxin. It is composed of the enzymatically active subunit of diphtheria toxin coupled to 
interleukin-2 (IL-2), and has now been approved for the treatment of patients with persistent or 
recurrent cutaneous T-cell lymphoma (Pastan et al., 2006; Wong et al., 2007). 
Due to their ability to reach the cytosol, toxins can be used as vectors to deliver antigens 
for proteasomal processing. The resulting peptides will then be presented by major 
histocompatibility complex (MHC) class I molecules at the cell surface. By using selected 
antigens, the aim is to provoke a specific immune response (Smith et al., 2002). 
Toxins are still a serious threat to human health. However, knowledge of how they target 
cells has made it possible to use them to our advantage in medicine. This serves as a great 
example of how important it is to understand the molecular mechanisms underlying intracellular 
trafficking. 
Mechanisms in intracellular transport of toxins 
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al., 2005; Slominska-Wojewodzka et al., 
2006). The toxins are recognised by the 
ERAD pathway due to their now unfolded 
state. ExoA, cholera toxin, Shiga toxin and 
ricin have all been found to interact with 
the Sec61 channel (Wesche et al., 1999; 
Schmitz et al., 2000; Koopmann et al., 
2000; Yu et al., 2005), and ricin has been 
shown to be transported through it 
(Simpson et al., 1999).  
ERAD substrates are normally 
targeted for degradation by proteasomes in 
the cytosol. How do toxins avoid this 
destiny? Sequence analysis of AB toxins 
that enter the cytosol via the ER revealed 
that lysine residues were rare, if not absent, 
in their A subunits (London and Luongo, 
1989). In contrast, toxins that do not travel 
to the ER have lysine residues distributed 
throughout their sequence (Hazes and 
Read, 1997). This feature was early 
proposed to be the mechanism for escaping 
ubiquitin-mediated protein degradation 
(Stein et al., 1996), and has later been 
shown to be true for ricin (Deeks et al., 
2002). 
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Aims of the thesis 
 
 
The overall goal of this work has been to increase our knowledge of mechanisms in 
intracellular transport, using toxins as model proteins. The specific aims of the 
different studies have been as follows: 
 
 
I Phosphoinositide-regulated retrograde transport of ricin: crosstalk between 
hVps34 and sorting nexins 
To investigate the role of phosphatidylinositol 3-phosphate (PI(3)P), produced by 
hVps34, in endosome to Golgi transport of ricin. And to identify effectors of PI(3)P in 
this pathway. 
 
II The Mitogen-activated Protein Kinase p38 Links Shiga Toxin-dependent Signaling 
and Trafficking 
To study the role of the signaling protein MAPK p38 in intracellular transport of Shiga. 
 
III SNX4 in complex with clathrin and dynein: implications for endosome movement 
 To study mechanisms in endosome to Golgi transport mediated by the hVps34 effector 
protein SNX4. 
  
IV arrestins attenuate p38 mediated endosome to Golgi transport 
 To identify effectors of the p38 regulated endosome to Golgi pathway used by Shiga 
toxin. 
  
Mechanisms in intracellular transport of toxins 
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Summary of the included papers 
 
 
Papers I and III, as well as II and IV, are more related to each other. For clarity, they 
are mentioned in this order below. 
 
 
I: Phosphoinositide-regulated retrograde 
transport of ricin: crosstalk between 
hVps34 and sorting nexins 
Different species of phophoinositides are 
known to localize to distinct membranes in 
the cell. PI(3)P is localized to early 
endosomes, multivesicular bodies (MVBs) 
and vacuoles (Gillooly et al., 2000), where 
it can serve as an anchor for PI(3)P binding 
proteins. We were interested in the role of 
PI(3)P and its effectors in endosome to 
Golgi transport of ricin. The PI3-kinase 
hVps34 is responsible for the major pool of 
PI(3)P on endosomes (Shin et al., 2005). 
By targeting this kinase, the endosomal 
level of PI(3)P will consequently be 
reduced. When the activity of hVps34 was 
inhibited, either by PI3-kinase inhibitors, 
by expressing dominant negative mutants 
of the kinase or by targeting small 
interfering RNA (siRNA) against its 
mRNA, we observed a reduced endosome 
to Golgi transport of ricin in HEK293 cells. 
The endocytosis of ricin remained 
unaffected by all these treatments.  
In cells with reduced hVps34 
activity, we observed ricin in endosomes 
positive for Rab7, a protein found on late 
endosomes. This was in contrast to the 
Golgi localization seen in control cells. 
The reduced Golgi transport observed in 
cells with inactive hVps34 could therefore 
possibly be due to retention of ricin in 
early endosomes that mature into late 
endosomes (Rink et al., 2005). 
 We were next interested in 
identifying effectors of this PI(3)P 
dependent pathway. Retromer is a protein 
complex involved in endosome to Golgi 
transport, and Vps34 has been shown to 
regulate retromer function in yeast (Burda 
et al., 2002). Two human orthologs of the 
retromer subunit Vps5, SNX1 and SNX2, 
have a PI(3)P binding PX domain, and 
were therefore of interest to us. 
Furthermore, the PI(3)P binding protein 
SNX4 has been shown to mediate an 
endosome to Golgi pathway different from 
the retromer in yeast (Hettema et al., 2003), 
and so we chose to study this protein as 
well. We observed that retrograde transport 
of ricin could occur normally in cells 
where SNX1 was knocked down. However, 
knockdown of either SNX2 or SNX4 
resulted in a similar reduction in ricin 
transport as when hVps34 was targeted. 
Furthermore, double knockdown of SNX2 
and SNX4 resulted in an additional 
reduction in ricin transport, suggesting that 
these proteins may mediate different 
endosome to Golgi pathways. 
 
III: SNX4 in complex with clathrin and 
dynein: implications for endosome 
movement 
Having established that SNX4 plays a role 
in retrograde transport of ricin (Paper I), 
we aimed at understanding the mechanisms 
underlying this event better. We started by 
screening for SNX4 binding partners, and 
identified clathrin, tubulin and dynein. 
These findings suggested that SNX4 
positive vesicles move on microtubuli 
guided by the minus-end directed motor 
protein dynein. This was confirmed by 
another report during our studies (Traer et 
al., 2007). The role of clathrin, however, 
was not obvious. To investigate its 
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function in ricin transport, we took 
advantage of siRNA. When clathrin was 
knocked down, an increased ricin transport 
to the Golgi was observed both by 
biochemical and imaging assays. 
Furthermore, also other endosomal 
proteins including EEA1, SNX4 and the 
transferrin receptor (TfR) were localized to 
the Golgi region in clathrin knockdown 
cells. Perinuclear localization of TfR and 
EEA1 has previously been demonstrated 
using a clathrin mutant (Bennett et al., 
2001). These data suggested that clathrin 
serves as a negative regulator of endosome 
transport.  
We characterized the clathrin 
interaction site on SNX4 to be a short 
sequence resembling the clathrin box motif 
(Dell'Angelica, 2001). Deletion of this 
motif reduced the SNX4-clathrin 
interaction with ~80%, and a small peptide 
displaying this sequence was sufficient to 
bind clathrin in vitro. Interestingly, the 
corresponding sequences in SNX1, SNX2 
and SNX3 were also able to bind clathrin 
in vitro. Like other clathrin boxes, we 
found that the SNX4 sequence bound the 
terminal domain of clathrin. 
We hypothesised that clathrin 
serves as a physical brake of SNX4 vesicle 
movement. Upon clathrin release, dynein 
may bind and thus mediate vesicle 
movement. To test this, we needed to 
characterize how the three proteins bind to 
each other. When clathrin was knocked 
down, dynein could still bind to SNX4, 
showing that clathrin is not required for the 
SNX4-dynein interaction. We further 
showed, by using the tubulin 
depolymerising agent nocodazole, that 
tubulin is not needed for the binding of 
either clathrin or dynein to SNX4. Rather, 
there was an increased binding of clathrin 
to SNX4 in the presence of nocodazole. 
This suggested that when the vesicle 
motility is affected due to altered tubulin 
network, SNX4 will remain bound to its 
“brake”. Finally, we observed that dynein 
bound to the same region of SNX4 as 
clathrin. This indicated that they do not 
bind to SNX4 simultaneously. 
 We propose a model in which 
clathrin serves as a negative regulator of 
SNX4 vesicle motility through its 
interaction with SNX4. When clathrin is 
released, dynein may bind to SNX4 and 
mediate retrograde transport. 
 
II: The Mitogen-activated Protein Kinase 
p38 Links Shiga Toxin-dependent 
Signaling and Trafficking  
Shiga toxin is known to induce signaling 
events upon cell binding or following its 
internalization (Katagiri et al., 1999; Ikeda 
et al., 2000; Mori et al., 2000; Cameron et 
al., 2003; Takenouchi et al., 2004; Lauvrak 
et al., 2006). Interestingly, some of these 
studies demonstrate that Shiga plays an 
active role in its own transport (Lauvrak et 
al., 2006; Hehnly et al., 2006). Our lab had 
recently shown that Shiga binding activates 
the tyrosine kinase Syk in HeLa cells, and 
several proteins, including clathrin, 
become phosphorylated (Lauvrak et al., 
2006). This results in an increased uptake 
of Shiga into cells. We were therefore 
interested in finding out whether Shiga can 
regulate other steps of its transport.  
 We observed that Shiga rapidly 
activated the mitogen-activated protein 
kinase (MAPK) p38. When p38 was 
targeted, either with chemical inhibitors or 
siRNA, endosome to Golgi transport of 
Shiga was reduced in both HeLa and HEp2 
cells. Interestingly, ricin was not affected 
by such treatments, suggesting that the 
requirement for p38 is specific to Shiga. 
 It has been known for a long  time 
that divalent ions are able to modulate 
Shiga transport (Sandvig and Brown, 
1987). Interference with calcium 
homeostasis affects both ricin and Shiga 
trafficking (Lauvrak et al., 2002). 
Furthermore, a link between Ca2+ and p38 
activation has been proposed (Chao et al., 
1992; Ikeda et al., 2000; Takeda et al., 
2004; Fazal et al., 2005). We therefore 
tested the involvement of Ca2+ in the p38 
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dependent pathway used by Shiga. We 
observed that Shiga strongly attenuated 
Ca2+ oscillations induced by histamine or 
ATP. The effect was seen after 15 minutes 
incubation with Shiga, suggesting that the 
toxin must be internalized in order to act. 
The effect was not dependent on p38, as 
p38 inhibition did not affect the outcome. 
We next demonstrated that Shiga transport 
is regulated by Ca2+, and that its 
requirement is part of the p38 pathway. 
 That p38 plays a role in endosomal 
trafficking suggests that it is localized to 
endosomes. We observed that part of it 
localized to endosomes positive for Shiga, 
and confirmed its endosomal localization 
by a biochemical endosome purification 
assay. Interestingly, p38 was recruited to 
the early endosome fraction upon Shiga 
stimulation in a Ca2+ dependent manner. 
 The observations that Shiga 
stimulates activation and endosomal 
recruitment of p38 required for its 
transport, clearly shows that Shiga has neat 
ways of promoting its own transport. 
 
IV: arrestins attenuate p38 mediated 
endosome to Golgi transport 
What are the p38 effectors required for 
Shiga transport? This was the question we 
wished to answer for our next study. -
arrestin 1 has been shown to bind to and 
co-localize with phosphorylated p38 
(McLaughlin et al., 2006; McLaughlin et 
al., 2008), while suppression of -arrestin 
2 blocks G-protein coupled receptor 
(GPCR) CXCR4-mediated activation of 
the MAPKs ERK (extracellular signal-
regulated kinase) and p38 (Sun et al., 
2002). We therefore chose to investigate 
whether -arrestins are effectors of the p38 
pathway used by Shiga in HEp2 cells.  
When either -arrestin 1 or -
arrestin 2 was knocked down by specific 
siRNAs, an increased endosome to Golgi 
transport of the toxin was observed. A 
number of studies have shown that -
arrestins play important roles in 
endocytosis of receptors (Lefkowitz and 
Whalen, 2004). It was therefore important 
to test whether knockdown of these 
proteins affected the uptake of Shiga. It did 
not, allowing us to conclude that it is the 
endosome to Golgi transport step that is 
regulated by -arrestins. 
 The increased Shiga transport upon 
-arrestin knockdown was in contrast to 
what was previously observed upon 
reduced p38 activity (Paper II). However, 
when we treated cells with the p38 
activator anisomycin, an equally increased 
Golgi transport was seen. To test whether 
-arrestin and p38 mediate the same 
pathway, we treated cells with both -
arrestin siRNA and anisomycin. No 
additional increase in Shiga sulfation was 
detected, suggesting that -arrestin and 
p38 act on the same transport route. 
Furthermore, combined knockdown of p38 
and -arrestin 1 resulted in the same 
phenotype as p38 knockdown alone. Cells 
with combined p38 and -arrestin 2 
knockdown were unhealthy. 
 We next studied the cellular 
localization of -arrestins. By confocal 
microscopy, we observed that they were 
localized to Shiga positive structures. Not 
only so, they even seemed to change their 
distribution in the presence of Shiga. To 
investigate this further, we performed 
cellular fractionation studies. As for p38, 
we found that the -arrestins were 
recruited to the early endosomal fraction 
upon stimulation with Shiga toxin. The 
same phenotype was observed upon 
anisomycin treatment. Since p38 is 
activated both by Shiga (paper II) and 
anisomycin, this suggested that -arrestin 
is recruited to endosomes in a p38P 
dependent manner. In order to confirm this, 
we performed fractionation experiments on 
p38 knockdown cells. At this condition, a 
strong reduction in the -arrestin 
recruitment was observed. 
 We next investigated whether an 
interaction between p38 and -arrestin 
could be detected in our system. Indeed, 
p38 and -arrestin co-immunoprecipitated 
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after Shiga treatment. Although we were 
unable to detect p38P in the precipitates, 
the time-point of the interaction correlated 
with activation of p38 by Shiga.  
 We suggest that -arrestin binds 
activated p38 and attenuates its signaling. 
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Discussion 
 
 
The work presented in this thesis has contributed to elucidate mechanisms in 
intracellular transport of ricin and Shiga toxin. We have shown that Shiga is able to 
regulate its own intracellular transport through signaling events, and identified 
effectors of this pathway. Our studies have further revealed mechanisms in 
endosome to Golgi transport of ricin. We have shown that SNX4 positive vesicles 
loaded with ricin are transported in a clathrin and dynein dependent manner, and 
that clathrin and dynein serve contrary roles in this regulated transport. 
 
 
hVps34 and effectors in transport 
hVps34 is the human homologue of yeast 
Vps34, and the only identified member of 
the class III PI3-kinases. This kinase 
phosphorylates phosphatidylinositol in its 
3-position to produce PI(3)P. This lipid is 
highly enriched on early endosomes and in 
the internal vesicles of MVBs, and in yeast 
vacuoles (Gillooly et al., 2000). As its 
name implies, Vps34 is required for 
vacuolar protein sorting in yeast (Schu et 
al., 1993). It has further been shown that 
hVps34 is needed for normal functioning 
of MVBs (Futter et al., 2001) as well as 
early to late endosomal transport (Stein et 
al., 2003). 
 Studies to better understand how 
PI3-kinases regulate membrane trafficking 
in mammalian cells have largely been 
based on the use of chemical inhibitors. 
These investigations in combination with 
biochemical approaches lead to the 
identification of the early endosomal 
antigen 1 (EEA1), which directly binds to 
PI(3)P (Patki et al., 1997). Further analysis 
revealed that a FYVE domain (named after 
four proteins initially found to contain this 
domain: Fab1, YGLO23, Vps27 and 
EEA1) at the C-terminal end of EEA1 was 
responsible for the specific binding to 
PI(3)P both in vitro and in vivo (Stenmark 
et al., 1996; Burd and Emr, 1998; Gaullier 
et al., 1998; Patki et al., 1998). EEA1 is an 
important regulator of endosome fusion 
(Simonsen et al., 1998; Christoforidis et al., 
1999). 
 Also other domains can bind 
phosphoinositides (Lemmon, 2003). A 
second PI(3)P binding domain is the Phox 
homology (PX) domain (Simonsen and 
Stenmark, 2001). A subgroup of this 
domain is found in the sorting nexin 
protein family (Teasdale et al., 2001). 
Members of this family are regulators of 
membrane trafficking. 
 
hVps34 and sorting nexins in ricin 
transport 
With this knowledge as background, we 
chose to study the role of hVps34 in 
intracellular transport of ricin. A reduced 
endosome to Golgi transport was observed 
upon hVps34 inhibition or knockdown 
(Paper I). We next wished to identify 
effectors of this pathway. As mentioned 
above, sorting nexins have been implicated 
in membrane trafficking. We selectively 
studied SNX1, SNX2 and SNX4, which all 
bind to PI(3)P. SNX1 and SNX2 have been 
suggested to be part of the retromer, while 
SNX4 has been shown to mediate an 
endosome to Golgi retrieval pathway 
different from the retromer in yeast 
(Hettema et al., 2003). We found that ricin 
transport was unaffected by SNX1 
knockdown, while both SNX2 and SNX4 
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were required for normal transport to the 
Golgi (Paper I).  
 SNX1 and SNX2 are human 
orthologs of the Vps5 subunit in the yeast 
retromer (Horazdovsky et al., 1997; Haft et 
al., 1998). While SNX1 has been shown to 
interact with the core retromer complex 
(Haft et al., 2000; Gullapalli et al., 2004), 
the role of SNX2 is still debated (Haft et 
al., 2000; Griffin et al., 2005; Carlton et al., 
2005; Rojas et al., 2006). Our results 
showing that SNX1 and SNX2 play 
different roles in ricin transport may 
suggest that they are not both part of the 
retromer, alternatively that they can also 
function without this complex. The latter is 
likely, as several proteins are known to 
serve different roles in cells. In either case, 
however, our findings suggest that the 
retromer is not critical for proper transport 
of ricin to the Golgi apparatus since 
knockdown of the established retromer 
component SNX1 did not affect ricin 
transport. 
 We further observed that 
simultaneous knockdown of SNX2 and 
SNX4 resulted in an additional reduction 
in ricin transport as compared to 
knockdown of either of the proteins alone. 
This indicates that SNX2 and SNX4 act on 
separate pathways. If we assume that the 
role of SNX2 in ricin transport is unrelated 
to retromer function, it is possible that at 
least three different endosome to Golgi 
pathways exist in mammalian cells. 
 
Partners of SNX4 at the endosome 
When we initiated our study on sorting 
nexins, very little was known about SNX4 
function. Since we found that it is needed 
for normal transport of ricin (Paper I), we 
were interested in investigating further the 
mechanisms underlying SNX4 mediated 
transport. As a start, we identified SNX4 
binding partners. Tubulin and the minus 
end-directed motor protein dynein were 
found in this screen, suggesting that SNX4 
vesicle movement is mediated by dynein 
on microtubuli. During the progress of our 
work, a publication confirmed that SNX4 
and dynein interact (Traer et al., 2007). In 
this study, SNX4 was found to play a role 
in sorting of the transferrin receptor 
between early and recycling endosomes 
(Traer et al., 2007).  
It has previously been reported that 
Rab5 can mediate endosome movement on 
microtubuli in an hVps34-dependent 
manner (Nielsen et al., 1999). In 
agreement with our studies, this report 
showed that treatment with the PI3-kinase 
inhibitor wortmannin, or inhibitory 
antibodies against hVps34, led to reduced 
minus-end directed motility (Nielsen et al., 
1999). The motor protein responsible for 
this movement was not identified (Nielsen 
et al., 1999). In a later study by the same 
group, however, the kinesin-3 KIF16B was 
found to transport early endosomes to the 
plus end of microtubules in a process 
regulated by Rab5 and hVps34 (Hoepfner 
et al., 2005). 
In our screen for SNX4 interacting 
proteins, we also identified clathrin (Paper 
III). Clathrin has mainly been studied for 
its role in endocytosis. However, in 
addition to its localization at the plasma 
membrane, clathrin can also be found on 
intracellular membranes. The interaction 
between SNX4 and clathrin clearly 
required endosomal localization of SNX4, 
as no interaction was observed in the 
presence of wortmannin (Paper III). 
Treatment with this PI3-kinase inhibitor 
leads to endosomal dissociation of SNX4 
(Paper I)(Traer et al., 2007).  In screens for 
clathrin interacting proteins, several sorting 
nexins have been reported, but not SNX4 
(Borner et al., 2006). The reason for this is 
not clear, but it could be due to a strict cut-
off in the analysis of the data, as neither 
the clathrin recruiting protein Hrs (Raiborg 
et al., 2001) was identified (Borner et al., 
2006). 
 
Why the attraction to SNX4? 
Having identified dynein and clathrin as 
SNX4 interacting partners, we focused our 
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further study on understanding how these 
proteins interact, and the role they serve in 
complex with SNX4. 
 A well established clathrin 
interacting motif is the so-called clathrin 
box (Dell'Angelica, 2001). This motif is 
only five amino acids long, and the 
consensus sequence is Lp(), where L 
is leucine,  denotes a bulky hydrophobic 
residue, p a polar residue, and () is a 
negatively charged residue (Dell'Angelica, 
2001). However, it is becoming clear that 
several versions of the clathrin box exist. 
Having found that SNX4 is a clathrin 
interacting protein (Paper III), we searched 
the SNX4 sequence for the presence of a 
clathrin box. The consensus sequence was 
not present. However, an “inverted” 
clathrin box was found in the PX domain, 
E109FELL113. When we deleted this 
sequence from SNX4, an ~80% reduction 
in clathrin binding was observed (Paper 
III). Furthermore, a small peptide 
displaying this motif was sufficient to pull 
down clathrin (Paper III). Like other 
clathrin boxes, the SNX4 sequence 
interacted with the terminal domain of 
clathrin. These data demonstrate that 
EFELL serves as a clathrin box in SNX4. 
Interestingly, the corresponding sequences 
in SNX1, SNX2 and SNX3 were also able 
to bind clathrin. We may thus have 
identified a new member of the clathrin 
boxes. We next performed an alanine scan 
of the SNX4 motif, meaning that each 
amino acid was replaced by an alanine, one 
at the time, to study their individual role in 
clathrin binding. The E109A mutant was 
still able to bind clathrin, perhaps even 
stronger than the wild type. While the four 
following mutants only showed 
background binding to clathrin (Paper III). 
This showed that especially the amino 
acids F110ELL113 were of importance for 
proper clathrin binding. 
 The clathrin motif in SNX4 is part 
of its PX domain. The sequence is located 
to the 1 helix, conserved among PX 
domain containing proteins (Seet and Hong, 
2006). The crystal structure of the PX 
domain from p40phox suggests that this 
alpha helix is available at the protein 
surface (Bravo et al., 2001). Interestingly, 
amino acids directly upstream of the 
clathrin motif in SNX4 are involved in the 
PI(3)P binding. Importantly, we cannot 
exclude that mutation analysis of this 
sequence might destabilize the alpha helix. 
However, the deletion mutant SNX4 109-
113 showed a similar cellular localization 
as the wild type (Paper III). 
 What is the purpose of the SNX4-
clathrin interaction? When SNX4 is 
knocked down, a reduction is seen in 
endosome to Golgi transport of ricin 
(Paper I). When clathrin was knocked 
down, however, the opposite effect was 
observed (Paper III). This suggested that 
clathrin serves as a negative regulator of 
ricin transport. We next studied clathrin 
knockdown cells by confocal microscopy, 
and saw that ricin was localized in large 
perinuclear structures together with SNX4. 
These structures were positive for the 
Golgi protein TGN46. This is in agreement 
with the role of SNX4 in ricin transport, 
and supports the biochemical data showing 
increased retrograde transport upon 
clathrin knockdown. 
 We hypothesised that clathrin 
serves as a physical brake of SNX4 vesicle 
movement. When clathrin is released from 
the complex, dynein can bind and mediate 
vesicle motility. Our data showing that 
dynein binds to SNX4 in a clathrin-
independent manner, together with the 
finding that clathrin and dynein bind to the 
same region of SNX4, support such an 
hypothesis. 
 
Conclusions from Papers I and III 
Our studies of ricin transport presented in 
this thesis have shown that endosomal 
PI(3)P produced by hVps34 is required for 
normal endosome to Golgi transport (Paper 
I). We found that SNX2 and SNX4, but not 
SNX1, are effectors of this pathway (Paper 
I). Interestingly, the three sorting nexins 
seem to mediate three different endosome 
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to Golgi pathways in cells. We 
have further shown that 
clathrin and dynein bind to 
SNX4 at the endosome (Paper 
III). From our data we propose 
a model in which clathrin 
serves as a brake of vesicle 
motility when bound to SNX4. 
When clathrin is released, 
dynein can bind and mediate 
vesicle movement (Fig. 4). 
 
Signaling 
When the human genome was sequenced 
in 2001, one of the biggest surprises was 
the small number of genes it encoded. At 
that time, it was reported to be around 
26000 protein coding genes (Venter et al., 
2001). Since then, the number has 
decreased, and it is now likely that a 
realistic number is closer to 18000, not 
much more than for the fruit fly 
Drosophila melanogaster. How is it 
possible that such a complex organism as 
the human does not have more genes? One 
of the explanations is that one protein can 
serve several roles in the cell, and its 
activity can be precisely tuned by small 
posttranslational modifications. 
 Phosphorylation is a 
posttranslational modification mediated by 
protein kinases, and the amino acids serine, 
threonine and tyrosine are the common 
targets. Protein phosphorylation may 
induce protein interactions, or lead to a 
change in the activity status of a protein. 
Depending on the protein, it can either be 
turned on or off by this modification. 
Signaling events are important for normal 
functioning of the cell, including its 
intracellular transport. When a ligand binds 
to its receptor at the plasma membrane, 
this may lead to autophosphorylation of the 
receptor and serve as signal for 
endocytosis, and thus silencing, of the 
ligand-receptor complex. 
Signaling mediated by Shiga 
As is the case when other ligands bind 
their receptors, Shiga triggers signaling 
events when binding to its cell surface 
receptor. A transient increase in 
microtubule levels is induced by Shiga 
binding (Takenouchi et al., 2004; Hehnly 
et al., 2006). Possibly, Shiga modifies the 
cytoskeleton in a manner that facilitates its 
retrograde transport (Hehnly et al., 2006). 
The tyrosine kinase Syk regulates both the 
clathrin-mediated endocytosis of Shiga 
(Lauvrak et al., 2006) as well as 
microtubule formation (Sulimenko et al., 
2006). It was therefore tested whether Syk 
mediates signaling between Shiga and the 
microtubuli, but this turned out negative 
(Hehnly et al., 2006). Binding of Shiga 
induces activation of Syk, which again 
phosphorylates several proteins, among 
them clathrin (Lauvrak et al., 2006). Syk 
activity is required for normal endocytosis 
of the toxin (Lauvrak et al., 2006), and 
thus this represents another example of 
how Shiga can induce signaling to promote 
its own transport. Also Yes and Lyn, two 
additional members of the Src family 
kinases, are activated by Shiga (Katagiri et 
al., 1999; Mori et al., 2000). Not only 
tyrosine kinases are activated by Shiga. 
Members of the serine/threonine MAP 
kinases, including ERK1/2, JNK and p38, 
are also shown to be activated by Shiga 
(Ikeda et al., 2000; Foster and Tesh, 2002; 
Cameron et al., 2003; Smith et al., 2003). 
However, these are often late events 
Figure 4: Simplified model of SNX4 mediated vesicle movement 
When SNX4 is bound to PI(3)P on endosomes, it can interact with 
clathrin, probably upstream of its interaction with dynein. When 
clathrin is released, SNX4 may gain access to dynein and the 
vesicle move on microtubuli. Additional proteins may be involved. 
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related to ribotoxic stress, a consequence 
of ribosomal inactivation by the toxin. 
 
p38 in Shiga transport 
Since it was known that Shiga is able to 
induce signaling events to enhance its 
transport, we set out to investigate whether 
the MAP kinase p38 was involved in Shiga 
transport. In agreement with previous 
reports, we found that Shiga activates p38, 
with a peak around 15 minutes (Paper II). 
When p38 was knocked down or inhibited 
with chemical inhibitors, we observed a 
reduced endosome to Golgi transport of 
Shiga (Paper II). Interestingly, the 
transport of ricin was not affected by these 
treatments. A link between p38 activity 
and Ca2+ has previously been proposed 
(Chao et al., 1992; Ikeda et al., 2000; 
Takeda et al., 2004; Fazal et al., 2005), and 
cytosolic Ca2+ levels are known to affect 
Shiga transport (Sandvig et al., 1987; 
Lauvrak et al., 2002; Chen et al., 2002). 
We therefore studied the effect of Shiga on 
Ca2+ homeostasis, and observed that Shiga 
strongly attenuated Ca2+ oscillations 
induced by ATP or histamine after 15 
minutes incubation (Paper II). This 
phenotype was not sensitive to p38 
inhibition. We next showed that the Ca2+ 
chelator BAPTA-AM, as well as TMB-8, 
an inhibitor of intracellular Ca2+ release, 
reduced endosome to Golgi transport of 
Shiga (Paper II). Furthermore, BAPTA-
AM efficiently inhibited p38 activation, 
suggesting that free intracellular Ca2+ is 
required for this process. Most 
interestingly, we discovered that p38 is 
recruited to early endosomes in a Ca2+ 
dependent manner upon Shiga stimulation 
(Paper II). These data clearly support a link 
between Ca2+ and active p38. Since the 
effect of Shiga on Ca2+ homeostasis was 
independent of p38 activity, while Shiga 
induced p38 activation required cytosolic 
Ca2+, we suggest that a Ca2+ signal is 
required for p38 activation. In agreement 
with this, our data show that p38 and Ca2+ 
mediate the same endosome to Golgi 
pathway, since there was no additional 
reduction in Shiga transport when 
treatments with TMB-8 and a p38 inhibitor 
were combined (Paper II). The Ca2+ 
requirement in endosome recruitment of 
p38 further confirm their crosstalk. 
 Although these findings are 
interesting in them selves, the role of Shiga 
adds another dimension to it. Without 
Shiga, we observed no activation of p38. 
And without Shiga, we observed no change 
in Ca2+ oscillations. In other words, Shiga 
induces signaling events which interplay 
and serve to enhance its transport. 
 
-arrestins in the p38 pathway 
Having established that p38 plays an 
important role in retrograde transport of 
Shiga, we next wanted to determine 
effectors of this pathway. We were 
interested in finding binding partners of 
p38 involved in Shiga transport. Recent 
reports have shown that -arrestin can 
scaffold GPCRs to MAP kinase cascades 
(McDonald et al., 2000), and a specific 
link to p38 has been reported (Sun et al., 
2002; McLaughlin et al., 2006). We 
therefore chose to investigate the role of -
arrestin in Shiga transport. 
 When either -arrestin 1 or -
arrestin 2 was knocked down with siRNA, 
a strong increase in endosome to Golgi 
transport of Shiga was observed (Paper IV), 
opposite of what was seen upon p38 
knockdown (Paper II). When cells were 
incubated with Shiga for 20 minutes, we 
detected an altered localization of -
arrestin by confocal microscopy. -arrestin 
and the toxin were observed in the same 
endosomal structures (Paper IV). We 
confirmed the protein redistribution by a 
biochemical assay where we purify 
endosomes. Upon Shiga incubation, -
arrestin was recruited to the early 
endosome fraction together with p38 
(Paper IV). This recruitment was possibly 
dependent on active p38, since we 
observed it also after treatment with 
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anisomycin, a p38 activator. And, 
importantly, p38 knockdown reversed this 
phenotype (Paper IV). -arrestin 1 has 
previously been shown to bind 
phosphorylated p38 (McLaughlin et al., 
2006), and -arrestins seem to have a 
preference for phospho proteins (Xiao et 
al., 2007). 
 When cells were treated with 
anisomycin, a strong increase was seen in 
endosome to Golgi transport of Shiga 
(Paper IV), similarly to what was observed 
upon -arrestin knockdown. To test 
whether p38 and -arrestin regulate the 
same pathway, we treated cells with both 
anisomycin and -arrestin siRNA. No 
additional effect should be observed if they 
mediate the same pathway, as was the case 
(Paper IV). Furthermore, combined 
knockdown of p38 and -arrestin 1 
resulted in the same phenotype as p38 
knockdown alone. From these data, we 
suggest that -arrestin is recruited to p38 
positive endosomes in a p38P dependent 
manner. We suggest that -arrestin binds 
to p38P and serves to attenuate its signal. 
This leads to an inhibition of Shiga 
transport. This view is in agreement with 
-arrestin’s role as silencer of receptor 
signaling at the plasma membrane 
(Lefkowitz et al., 2004). 
 
Conclusions from Papers II and IV 
Our studies show that Shiga is an active 
player in its own transport. Upon Shiga 
binding, p38 is activated and recruited to 
endosomes in a Ca2+ dependent manner. 
These events are required for proper 
endosome to Golgi transport of the toxin 
(Paper II). We have further identified -
arrestin 1 and -arrestin 2 as effectors of 
this pathway. -arrestins negatively 
regulate endosome to Golgi transport of 
Shiga, and are recruited to endosomes in 
what seems to be a p38P dependent 
manner. We suggest that -arrestins bind 
active p38 and attenuate its signaling (Fig. 
5). 
Figure 5: Tentative model of how p38 and -arrestin regulate Shiga transport 
When Shiga toxin reaches the endosome, a change in ATP/histamine-induced Ca2+ oscillations is detected (1). 
p38 is recruited to early endosomes in a Shiga and Ca2+ dependent manner, and active p38 is required for 
proper endosome to Golgi transport of Shiga (2). -arrestin is recruited to early endosomes upon p38 
activation, and is a negative regulator of Shiga transport (3). 
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Experimental systems 
 
 
A variety of methods have been employed in order to achieve the results presented 
in this thesis. Detailed descriptions of all these methods are included in the 
respective publications, while a brief overview of some important techniques is 
presented below. 
 
 
Cell lines 
The studies presented in this thesis have 
been performed on cultured cell lines, the 
minimal model system for the human 
organism. We have taken advantage of 
three different cell lines for our purposes. 
The human embryonic kidney cell line 
HEK293 was chosen for our studies of 
PI(3)P and SNX mediated ricin transport. 
These cells are easily transfected, an 
important determinant for our selection. 
When the p38 study was initiated, we 
chose to use the HeLa cell line. These cells 
are derived from cervical cancer cells in 
the patient Henrietta Lacks (Jones, 1997). 
They are commonly used worldwide, and 
unlike the HEK293 cells, they are sensitive 
to Shiga toxin. In the progress of our study, 
however, we discovered that it was 
difficult to isolate endosomes from these 
cells with the protocol available, and chose 
to do those experiments in HEp2 cells. 
Since there are variabilities between cell 
lines, we needed to confirm that the 
requirement for p38 in Shiga transport was 
the same as in HeLa cells. In the follow-up 
story with -arrestin, we used only HEp2 
cells for simplicity. The HEp2 cells 
originate from larynx carcinoma (Moore et 
al., 1955). 
Transient transfection and knockdown 
Common for the four papers included in 
this thesis is the study of which role 
selected proteins play in intracellular 
transport. To be able to study this, we have 
taken advantage of both transient 
expression of wildtype and mutant proteins, 
as well as knockdown of the protein of 
interest. The phenotype observed under 
such conditions gives a hint to the protein’s 
role under normal conditions.  
 RNA interference (RNAi) is a 
method where small interfering RNA 
(siRNA) is used to target specific genes for 
silencing (Tuschl, 2001). There are two 
major steps to silencing (Fig. 6). First, the 
 
 
 
Figure 6:  The RNAi pathway 
Double-stranded RNA is processed into siRNA by 
Dicer. RISC binds to the siRNA and guides the 
antisense strand to the target mRNA for destruction. 
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introduced double-stranded RNA (dsRNA) 
is recognized by Dicer, an enzyme of the 
RNase III family of nucleases, and the 
dsRNA is cut into small double-stranded 
molecules termed siRNA. Next, an RNA-
induced silencing complex (RISC) binds 
the siRNA and guides the antisense strand 
to the target mRNA. This causes cleavage 
of the target mRNA and further 
degradation. 
 In this work, both vector-based and 
oligo-based RNAi were applied. The oligo-
based approach is now the most common, 
as one can easily order synthetic RNA 
ready to use from several companies. 
However, advantages with the vector-
based approach are that it is cost-effective, 
and one can easily produce more of the 
construct when needed. It may also be 
more efficient than oligo-based siRNA 
since the product of the vector is 
continuously produced in the cell. On the 
other hand, it is more difficult to regulate 
the amount of siRNA in the cells by this 
approach. 
 
Measurement of transport to the Golgi 
apparatus 
In order to measure the amount of toxin 
that reaches the TGN, we have taken 
advantage of the fact that sulfation is a 
protein modification that takes place only 
in that compartment. Modified Shiga and 
ricin molecules containing sulfation sites 
have been constructed (Rapak et al., 1997). 
By performing toxin incubations in 
medium where the only sulfate source is 
radioactive sulfate, one can easily measure 
the amount of toxin that has reached the 
TGN by quantifying their radioactive 
labelling. 
 
Confocal microscopy 
To visualize where proteins are located in 
cells, we have performed 
immunofluorescence experiments using 
confocal microscopy. When we study fixed 
cells, we use fluorescent antibodies to label 
the proteins of interest, making it possible 
to detect them with the microscope. It is 
also possible to directly fuse a fluorophore 
to the protein of interest, such as the green 
fluorescent protein GFP. In this way, one 
can avoid problems with poor antibodies or 
limited antibody availability. However, it 
is important to be critical to results 
obtained with overexpressed proteins as 
their effect may deviate from that of the 
endogenous protein. 
Mechanisms in intracellular transport of toxins 
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Shiga toxin (Stx) binds to the cell, and it is transported via endosomes and the Golgi apparatus to the endoplasmic
reticulum and cytosol, where it exerts its toxic effect. We have recently shown that Stx activates the tyrosine kinase Syk,
which in turn induces clathrin phosphorylation and up-regulates Stx uptake. Here, we show that toxin-induced signaling
can also regulate another step in intracellular Stx transport. We demonstrate that transport of Stx to the Golgi apparatus
is dependent on the mitogen-activated protein kinase p38. Treatment of cells with chemical inhibitors or small interfering
RNA targeting p38 inhibited Stx transport to the Golgi and reduced Stx toxicity. This p38 dependence is speciﬁc to Stx,
because transport of the related toxin ricin was not affected by p38 inhibition. Stx rapidly activated p38, and recruited it
to early endosomes in a Ca2-dependent manner. Furthermore, agonist-induced oscillations in cytosolic Ca2 levels were
inhibited upon Stx stimulation, possibly reﬂecting Stx-dependent local alterations in cytosolic Ca2 levels. Intracellular
transport of Stx is Ca2 dependent, and we provide evidence that Stx activates a signaling cascade involving cross talk
between Ca2 and p38, to regulate its trafﬁcking to the Golgi apparatus.
INTRODUCTION
Shiga toxin (Stx) is composed of a cell-binding B-moiety and
an enzymatically active A-subunit. The toxin binds to the
target cell, and it is subsequently taken up by endocytosis. It
is then transported via early endosomes, and the Golgi
apparatus to the endoplasmic reticulum (ER), from where it
retrotranslocates to its ﬁnal destination, the cytosol. The
toxic effect of Shiga is to inactivate ribosomes and thus
inhibit protein synthesis.
It is now accepted, in the case of hormone receptors, that
ligand-binding induced changes in receptor structure can
stimulate an intrinsic kinase activity or an associated kinase.
The signaling cascade induced by receptor stimulation can
also regulate endocytosis (Gonzalez-Gaitan and Stenmark,
2003; Polo and Di Fiore, 2006). The importance of kinase-
mediated signaling in endocytosis and intracellular trans-
port has been demonstrated by a genome-wide analysis
(Pelkmans et al., 2005). Another important ﬁnding was that
p38 is able to regulate formation of the Rab5–guanine nu-
cleotide dissociation inhibitor (GDI) complex (Cavalli et al.,
2001). Furthermore, the Rab5 effectors Rabenosyn-5 and
early endosome antigen 1 (EEA1) are substrates for p38
(Mace et al., 2005). Interestingly, mitogen-activated protein
(MAP) kinases are known to associate with endosomes (Pol
et al., 1998), and this has been demonstrated for p38 as well.
p38 has been puriﬁed with the endosome fraction in a su-
crose gradient (Delcroix et al., 2003), and it also has been
observed on endosomal structures, by confocal microscopy
(Pelkmans et al., 2005). Recently, it was demonstrated that
p38 can be recruited to a signalosome involved in the reg-
ulation of the platelet-activating factor-induced clathrin-
mediated endocytosis (McLaughlin et al., 2006). Taken to-
gether, p38 can be localized on endosomes to phosphorylate
downstream effectors from here.
Several studies have shown that Stx, upon binding or
entry into cells, is able to trigger signaling cascades (Katagiri
et al., 1999; Ikeda et al., 2000; Mori et al., 2000; Cameron et al.,
2003; Takenouchi et al., 2004). However, the main focus has
been on Stx-induced apoptosis and signaling related to this
late event. Interestingly, not only the tyrosine kinases have
been shown to be activated upon Stx intoxication (Foster and
Tesh, 2002; Smith et al., 2003). However, such kinases are
mostly activated upon ribotoxic stress, a cellular response
that occurs as a consequence of toxin-induced ribosomal
inactivation in the cytosol. We have previously presented
data demonstrating that Stx is an active player in its own
transport. We have shown that Stx binding activates the
tyrosine kinase Syk, and several proteins, one of these pro-
teins being clathrin heavy chain (CHC), are phosphorylated
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(Lauvrak et al., 2006). For Stx, which binds to a glycolipid
and not to a transmembrane protein receptor, one may ask
what triggers a signaling cascade in the cytosol. So far, this
is not known. However, signaling is not only caused by
phosphorylation of receptors but also Ca2 currents can
mediate downstream cytosolic phosphorylations. It has been
known for two decades that divalent ions are able to mod-
ulate Stx trafﬁcking (Sandvig and Brown, 1987) and that in
Madin Darby canine kidney cells, ricin and, to a lesser
extent, Stx transport is sensitive to interference of Ca2
homeostasis (Lauvrak et al., 2002). Furthermore, early cellu-
lar events that might precede phosphorylation cascades
were detected in B-cells stimulated by Stx. Taga et al. (1997)
have shown that exposing Burkitt’s lymphoma cells to Stx
triggers a Ca2 inﬂux. These events were, however, linked to
apoptotic signaling rather than regulation of transport
(Cherla et al., 2003). A link between Ca2 and p38 activation
has been proposed in Vero cells (Ikeda et al., 2000). However,
in this study, p38 activation was dependent on entry of the
active A subunit, thus presumably caused by ribotoxic stress.
In the present study, we have investigated the importance
of the MAP kinase p38 and Ca2 in the regulation of Stx
transport. We show that p38 is rapidly activated by Stx and
that its activity is required for transport of Stx from endo-
somes to the Golgi apparatus. p38-regulated trafﬁcking
seems to be speciﬁc to Stx, because transport of the related
toxin ricin was insensitive to p38 inhibition. In addition, Stx
is able to modulate oscillations in Ca2 levels caused by the
addition of ATP or histamine, suggesting a link between Stx
trafﬁcking and Ca2 homeostasis. We further show that
cytosolic Ca2 seems to be necessary for proper targeting of
p38 to the endosomes. Taken together, our data support a
model in which Stx, by modifying Ca2 homeostasis, recruits
p38 to endosomes to regulate its intracellular transport.
MATERIALS AND METHODS
Cell Lines, Products, and Reagents
HeLa and HEp2 cells were grown under 5% CO2 in DMEM with 10% fetal calf
serum supplemented with penicillin at 100 U/ml, streptomycin at 100 U/ml,
and l-glutamine at 2 mM (Invitrogen, Carlsbad, CA). SB203580 was from
Calbiochem (San Diego, CA), SKF86002 was from Sigma-Aldrich (St. Louis,
MO), and 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester (TMB-8)
was from Alexis Biochemicals (Lausen, Switzerland). [3H]Leucine was from
PerkinElmer Life and Analytical Sciences (Boston, MA). All cell culture reagents
were from Invitrogen (Paisley, United Kingdom). Stx1 was obtained from Na-
calai Tesque (Kyoto, Japan), and Stx was a kind gift from J. V. Kozlov (Academy
of Sciences of Russia, Moscow, Russia) and J. E. Brown (U.S. Army Medical
Research Institute of Chemical Defense, Fort Detrick, MD). The antibodies used
in this study were anti-Stx (anti-STX1-13C4; Toxin Technology, Sarasota, FL),
anti-ricin (Sigma-Aldrich), anti-p38 (p38 and p38P [pT180/pY182]; BD Bio-
sciences, Palo Alto, CA), anti-p382 (Zymed Laboratories, South San Francisco,
CA), anti-p38 (Cell Signaling Technology, Beverly, MA), anti--tubulin (Sigma-
Aldrich), anti-clathrin heavy chain (RDI Division of Fitzgerald Industries Inter-
national, Concord, MA), and anti-Rab5, anti-EEA1, and anti-annexin (our collec-
tion). StxB-Sulf2 expression construct was a kind gift from Dr. B. Goud (Institut
Curie, Paris, France). StxB-Sulf2, and ricin-Sulf1 were prepared as described
previously (Rapak et al., 1997; Lauvrak et al., 2006).
Small Interfering RNA (siRNA) Design and Transfection
Two different siRNAs targeting different parts of p38 and p38 mRNAs
were designed. They were selected according to their physicochemical pro-
ﬁles and their speciﬁcity to the target mRNA by BLAST analysis proﬁle
(http://www.ncbi.nlm.nih.gov/BLAST/), and they were ﬁtted as closely as
possible to the criteria depicted in Reynolds et al. (2004). p38 siRNA target
sequences were as follows: p38, 5-GCUGUUGACUGGAAGAACA-3 and
5-CUGCGGUUACUUAAACAUA-3 (siRNA1 and -2, respectively) and p38,
5-AAGGACCUGAGCAGCAUCUU-3 and 5-AAGUGUACUUGGUGACCACC-3
(siRNAb1 and -b2, respectively). High-performance liquid chromatography-
puriﬁed p38 siRNAs were ordered from MWG Biotech (Ebersberg, Germany),
and a negative control siRNA was from Eurogentec (Seraing, Belgium). Cells
were transiently transfected with the indicated siRNA by using Oligo-
fectamine (Invitrogen) according to the manufacturer’s protocol.
Calcium Analysis
Variations in cytosolic calcium concentrations were measured using the cal-
cium probe Fura-2 as described previously (Maturana et al., 2002). Cells were
loaded for 20 min at room temperature with the membrane permeant Fura-2
acetoxymethyl ester (AM) in medium containing 140 mM NaCl, 5 mM KCl,
1.2 mM Ca2, 1 mM MgCl2, 10 mM glucose, and 20 mM HEPES, pH 7.4.
Fura-2 ﬂuorescence (excitation, 340/380 nm; emission, 510 nm) was moni-
tored with an imaging system. Loaded cells plated on coverslips were
mounted on an IX70 inverted microscope (Olympus, Tokyo, Japan), and
measurements were performed at 37°C (Thermoplate from Tokai Hit, Shi-
zuoka, Japan) unless otherwise indicated. Images were captured with a
charge-coupled device Orca-ER camera (Hamamatsu, Shizuoka, Japan). The
cells were illuminated with a 75-W xenon lamp through a 10% neutral density
ﬁlter (Omega Optical, Tokyo, Japan), a Lambda 10-2 ﬁlter wheel (Sutter
Instrument, Novato, CA), and a 60 oil immersion PlanApo objective lens
(numerical aperture. 1.4; Olympus). Camera and ﬁlter wheel shutter were under
the control of the MetaMorph software (Molecular Devices, Sunnyvale, CA).
Endocytosis Assays
Stx internalization was quantiﬁed following the procedure described previ-
ously (Torgersen et al., 2005).
Sulfation Assays
Transfected or untransfected HeLa cells were washed twice with sulfate-free
medium (minimal essential medium 12-126; Lonza Walkersville, Walkers-
ville, MD) before incubation with 0.2 mCi/ml Na235SO4 in the same medium
for 3 h at 37°C. Inhibitors were added as indicated, and then they were
present in the same medium during the last 30 min of this incubation. Cells
were incubated with StxB-Sulf2 for 45 min or ricin-Sulf1 for 3 h. They were
then washed twice with cold phosphate-buffered saline (PBS) and lysed in
lysis buffer (0.1 M NaCl, 10 mM Na2HPO4, pH 7.4, 1 mM EDTA, 1% Triton
X-100, and 60 mM n-octyl--glucopyranoside, supplemented with Complete
protease inhibitors; Roche Diagnostics, Mannheim, Germany). Cleared lysate
was immunoprecipitated with anti-Stx or anti-ricin antibodies. The immuno-
precipitated complex was separated by SDS-polyacrylamide gel electrophore-
sis (PAGE), transferred to a polyvinylidene diﬂuoride (PVDF) membrane, and
investigated by autoradiography. Band intensities were quantiﬁed using Im-
ageQuant 5.0 software (Molecular Dynamics, Sunnyvale, CA). Total cellular
protein sulfation was measured as the amount of 5% trichloroacetic acid
(TCA)-precipitated 35SO42 in the lysates.
Subcellular Fractionation of Endosomes
HEp2 cells were starved in serum-free medium for 1 h before treatment with or
without 100M TMB-8 for 30 min. The cells were then incubated with or without
250 ng/ml StxB for 20 min in the same medium. Endosomes were puriﬁed as
described previously (Aniento et al., 1996). Brieﬂy, the cells were homogenized in
homogenization buffer (250 mM sucrose and 3 mM imidazole, pH 7.4), and the
postnuclear supernatant (PNS) was adjusted to 40% sucrose, 3 mM imidazole,
pH 7.4. The PNS was then subjected to equilibrium ﬂotation through layers of
35%, 25%, and 250 mM sucrose solutions in 3 mM imidazole, pH 7.4. The visible
bands at the PNS/35%, 35%/25%, and 25%/250 mM sucrose solution interfaces
correspond to the “heavy” membrane (HM), early endosome (EE), and late
endosome (LE) fractions, respectively (Aniento et al., 1996). The protein concen-
trations in the puriﬁed fractions were measured, and equal amounts of protein
were separated by SDS-PAGE and analyzed by Western blotting.
Immunoprecipitation
Detection of phosphorylated proteins after Stx stimulation was performed as
follows: HeLa cells were starved in HEPES medium for 2 h and treated with
250 ng/ml StxB for the indicated durations. The cells were then lysed in
binding buffer (20 mM Tris-HCl, 10 mM EDTA, 100 mM NaCl, 1% NP-40, and
0.2 mM orthovanadate) supplemented with a Complete protease inhibitor
cocktail (Roche Diagnostics). Tyrosine-phosphorylated proteins were immu-
noprecipitated overnight at 4°C by using 20 l of the slurry of an anti-
phosphotyrosine column (Upstate Biotechnology, Charlottesville, VA) in
batch as described previously (Wa¨lchli et al., 2004). The eluate was subjected
to SDS-PAGE and transferred onto a PVDF membrane. Immunostaining was
performed with the indicated antibodies.
Cytotoxicity Assays
HeLa cells were pretreated as indicated in the ﬁgure legends. The cells were
washed twice with leucine-free medium, and then they were incubated with
increasing concentrations of toxin (Stx or ricin) for 2.5 h. After this, cells were
incubated for 30 min in the presence of 2 Ci/ml [3H]leucine, and ﬁnally they
were extracted twice with 5% TCA. The precipitate was dissolved in 0.1 M
KOH, and the associated radioactivity was measured.
Confocal Fluorescence Microscopy
Cells grown on glass coverslips were transfected with siRNA against p38 or
p38, and they were analyzed 2 days after transfection. Alternatively, the cells
S. Wa¨lchli et al.
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were treated with or without 30 M SB203580 for 30 min, and then they were
incubated with 2 g/ml StxB for 20 min. For experiments with ricin, the
concentration used was also 2 g/ml. The cells were ﬁxed with 10% Formalin
solution (Sigma-Aldrich), permeabilized with 0.2% Triton X-100 in PBS, and
immunostained with appropriate antibodies. Fluorophore-labeled secondary
antibodies were from Jackson ImmunoResearch Laboratories (West Grove,
PA). DRAQ5 (Alexis Biochemicals, San Diego, CA) was used to stain the
nuclei. The cells were mounted in Mowiol (Calbiochem), and then they were
examined by laser scanning confocal microscope LSM 510 META (Carl Zeiss,
Jena, Germany). Images were prepared with the LSM Image Browser software
(Carl Zeiss).
RESULTS
Retrograde Trafﬁcking of Stx Is Dependent on p38
Stx induces early signaling events that can regulate endocy-
tosis, and possibly also intracellular transport, of the toxin
(Lauvrak et al., 2006). To analyze the involvement of kinases
in Stx transport, we undertook an unbiased screen of speciﬁc
kinase inhibitors. In this screen, the MAP kinase p38 stood
out as a candidate regulator of retrograde Stx transport. We
performed a sulfation experiment (Johannes et al., 1997), a
biochemical approach that allows quantiﬁcation of the
amount of Stx that reaches the trans-Golgi network (TGN)
(see Materials and Methods). The p38 inhibitors SB203580 and
SKF86002 reduced Stx sulfation to 50% (Figure 1a), suggest-
ing that p38 activity is required for transport of Stx to the
Golgi apparatus. This was conﬁrmed visually by confocal
immunoﬂuorescence microscopy. Cells treated with SB203580,
displayed a threefold reduction in colocalization between Stx
and the Golgi marker Giantin (Figure 1b).
Next, we designed siRNAs that speciﬁcally targeted the
p38 or p38 isoforms. Two days after transfection with
p38 siRNA, when p38 knockdown was almost complete
as determined by Western immunoblot (Figure 1c), trans-
port of Stx to the Golgi was reduced to a similar extent as
observed with the chemical inhibitors against p38 (Figure
1d). Because the available antibodies did not allow us to
detect p38 by Western immunoblot, we took advantage of
confocal microscopy to verify the siRNA-mediated knock-
Figure 1. p38 inhibition reduces transport of StxB, but not ricin, to the TGN. (a) HeLa cells were incubated with radioactive sulfate for 3 h,
and the indicated inhibitors (SKF86002 and SB203580; 30 M) or the carrier (dimethyl sulfoxide [DMSO]; 0.1% ﬁnal concentration) were
present for the last 30 min. StxB was then added, and the incubation was continued for 45 min. StxB was immunoprecipitated from the
lysates, and its degree of sulfation was analyzed by SDS-PAGE and autoradiography. The band intensities were quantiﬁed and the average
plotted with error bars showing deviations. The experiment was performed three times with duplicates. (b) HeLa cells were incubated with
or without SB203580 for 30 min, before addition of and further incubation with 2 g/ml StxB for 20 min. The cells were then ﬁxed and
permeabilized before staining with the indicated antibodies. DRAQ5 was used for nuclear staining. Bar, 10 m. Colocalization of StxB with
the Golgi marker Giantin was quantiﬁed using Zeiss LSM Image Browser. Bars represent SD; n  10. (c) We analyzed 1/100 of the Stx-IP
supernatant (from D) for p38 by Western blot. -Tubulin was used as loading control. (d) As in a, but in this case cells were transfected with
100 nM of the indicated siRNA and incubated for 48 h before StxB-Sulf2 treatment. These experiments were repeated at least three times with
duplicates. (e) Cells were incubated for 20 min with 2 g/ml Stx and 2 g/ml ricin before ﬁxation and permeabilization. They were then
stained with antibodies as indicated. Bar, 10 m. (f) As in d, but with 90-min incubation of ricin sulf-1 instead of StxB-Sulf2.
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down of p38. As shown in Supplemental Figure S1A, p38
was knocked down to a similar extent as p38 with the
respective siRNAs (compare bottom and top panels). Trans-
fection of cells with siRNAs targeting p38 did not affect the
level of Stx sulfation, that is, the transport of Stx to the TGN
(Supplemental Figure S1B). These observations suggest a
role for the p38 isoform only, in regulation of Stx transport.
We routinely check the total levels of protein sulfation under
the various experimental conditions, and no signiﬁcant dif-
ferences between inhibitor- or siRNA-treated cells and con-
trol cells were observed (data not shown).
To determine whether the effect of p38-inhibition/p38-
knockdown on retrograde transport to the TGN is speciﬁc
for Stx, or whether it is involved in transport to the TGN in
general, we investigated the transport of the related toxin
ricin. In contrast to Stx, which binds speciﬁcally to the gly-
cosphingolipid Gb3, ricin binds to both glycolipids and gly-
coproteins with terminal galactose. Ricin and Stx are thus
endocytosed by different mechanisms, and their nonover-
lapping endosomal localization is shown in Figure 1e. Anal-
ogous to what was done for Stx, we investigated the retro-
grade transport of a sulfation site-containing version of ricin
(Rapak et al., 1997). Treatment of cells with either SB203580
(data not shown) or p38 siRNA (Figure 1f) had no signiﬁ-
cant effect on ricin sulfation. Thus, p38 is speciﬁcally in-
volved in TGN transport of Stx, and not in general transport
to the Golgi apparatus.
Stx Endocytosis Is Independent of p38
The observed reduction in Stx transport to the Golgi appa-
ratus may be due to inhibition of a speciﬁc transport step
between endosomes and TGN, or to inhibition of earlier
events, like binding or endocytosis. Long-term inhibition of
p38 by SB203580 has been shown previously to reduce bind-
ing of Stx to human brain endothelial cells (Stricklett et al.,
2005). We therefore tested the effect of the two p38 inhibi-
tors, SB203580 and SKF86002, on binding and endocytosis of
Stx in our cells. Neither of the inhibitors affected toxin bind-
ing (data not shown). However, a slight decrease in Stx
uptake was observed in cells treated with SB203580 (Figure
2, black bars). This effect was not due to a general block in
clathrin-dependent endocytosis, because the transferrin en-
docytosis was unaffected by the inhibitor, both after 5 and 20
min (data not shown; Figure 2, gray bars). Importantly, the
siRNAs targeting p38 did not reduce binding or endocy-
tosis of Stx (data not shown). From these data, we conclude
that the main regulatory activity of p38 on Stx transport is
on the step from endosomes to the Golgi apparatus.
Depletion of p38 Protects Cells against Stx Toxicity
Because knockdown of p38 resulted in a strong reduction
in endosome to Golgi transport of Stx, we wanted to study
the effect on Stx transport to the cytosol. To this end, we
performed a toxicity assay. As shown in Figure 3, a and b,
the p38 inhibitor SB203580 and siRNA against p38 were
able to decrease the toxicity of Stx four- to ﬁvefold. This is in
agreement with the sulfation and immunoﬂuorescence data,
and it further shows that p38 is required for proper Stx
transport. We have reported previously that toxins are
sometimes able to overcome a block in their trafﬁcking
(Llorente et al., 2003), apparently by using compensatory
transport pathways up-regulated by the cell. However, for
p38, even after long-term inhibition (siRNA treatment), the
cells did not seem to be able to compensate for the lack of the
p38 kinase in trafﬁcking. To further conﬁrm that the ob-
served effects were speciﬁc for Stx transport, we performed
analogous experiments for ricin. In agreement with data
from sulfation experiments, ricin toxicity was not affected by
treatment with p38 inhibitor or siRNA (Figure 3, c and d).
Together, these results conﬁrm that p38 is required for
proper trafﬁcking of Stx, but not ricin.
p38 Is Activated by Stx
Previous reports have shown that the MAP kinase p38 is
a regulator of endosomal transport (Cavalli et al., 2001;
Delcroix et al., 2003; Fratti et al., 2003; Mace et al., 2005;
Pelkmans et al., 2005). Therefore, we aimed at testing
whether Stx can activate p38. Lysates of cells treated with
Stx for different times were passed through an anti-phos-
photyrosine (anti-YP) column, and eluted proteins were sep-
arated by SDS-PAGE and transferred to a PVDF membrane
for immunoblot analysis. As shown, activated (Tyr- and Thr-
phosphorylated) p38 (p38P) bound to the anti-YP column
already after 1 min of Stx stimulation of the cells, and a peak
was observed after 10–15 min (Figure 4a, top). The mem-
brane was also probed for p38 (Figure 4a, second panel
from the top). The observed binding of this isoform to the
anti-YP column suggests that at least part of the p38P bands
represent activated p38. However, due to poor antibodies
we were not able to detect p38 in immunoblots, and one
can therefore not exclude that the p38P bands also contain
activated p38. p38P shows a peak that seems to be a bit
delayed compared with p38. The p38P-antibody recognizes
the doubly phosphorylated (Thr and Tyr) protein, whereas
the column binds Tyr-phosphorylated proteins. The p38
antibody does not distinguish between the different phos-
phorylation states of the protein, and this might therefore
explain the seemingly different phosphorylation kinetics for
p38P and p38. As a control, the membrane was reprobed
with anti-CHC antibody, because we have previously shown
that CHC becomes phosphorylated upon Stx binding (Fig-
ure 4a, third panel from the top; Lauvrak et al., 2006). As
shown, also the kinetics of CHC phosphorylation is rapid.
As a control of equal loading to the columns, the whole cell
lysate (WCL) was probed against p38 (Figure 4a, bottom).
We also tested the sensitivity of the p38 response to different
Stx concentrations. p38 activation (Tyr and Thr phosphory-
Figure 2. Effect of p38 inhibition on endocytosis. HeLa cells were
incubated with 30 M SB203580 (SB) or carrier (DMSO; 0.1% ﬁnal
concentration) for 30 min at 37°C before Stx-SS-Biotin (black bars) or
transferrin-SS-Biotin (Tfn; gray bars) was added to the medium. The
incubation was continued for 20 min. Cells were 2-mercaptoethane
sulphonate sodium treated, and internalized Stx- or transferrin-SS-
Biotin labeled with Ru(II)-tag either directly (transferrin) or via
antibody (Stx) was ﬁshed out from cell lysates by streptavidin-
coated magnetic beads and measured by electrochemiluminescence.
This experiment was repeated three times with duplicates; error
bars represent deviations. *p  0.005, determined by the paired
Student’s t test.
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lation) was analyzed after 5-min incubation with increasing
concentrations of Stx (Figure 4b). Whole cell lysates were
subjected to SDS-PAGE and analyzed by Western immuno-
blot. As presented, Stx concentrations as low as 10 ng/ml
were able to stimulate p38 phosphorylation.
Stx Modiﬁes the Intracellular Ca2 Response to Agonists
Because cytosolic Ca2 levels affect Stx transport (Sandvig
and Brown, 1987; Chen et al., 2002; Lauvrak et al., 2002), we
analyzed the effect of Stx binding on Ca2 homeostasis. In
contrast to data obtained from studies in B cells (Taga et al.,
1997), binding of Stx itself (unlike addition of ionomycin)
did not induce any observable Ca2 response in HeLa cells
(Supplemental Figure S2A). The same was observed when
puriﬁed StxB was added to the cells (Supplemental Figure
S2D, left). This may be due to a local effect of Stx signaling,
not measurable with a cytosolic calcium probe such as Fura-
2AM, or, alternatively, a negative response. To test whether
Stx addition modiﬁes Ca2 ﬂuxes, we investigated the effect
of Stx on histamine- or ATP-induced oscillations in Ca2
levels. Stx was added to the cells, and histamine was then
added after different time points (20 s, and 4, 10, and 15 min;
Figure 5, a–d, respectively). No signiﬁcant effect on the
cytosolic Ca2 oscillations induced by histamine could be
observed at the earliest time points (Figure 5, a–c). After 15
min, however, the cytosolic Ca2 oscillations induced by
histamine were strongly attenuated, despite the fact that an
intracellular Ca2 increase was still observed (Figure 5d).
The same was observed after ATP stimulation (Supplemen-
tal Figure S2B) and for StxB (Supplemental Figure S2C).
These results suggest that Stx must be taken up by the cell to
exert its effect on cytosolic Ca2 levels. We next investigated
whether the observed attenuation of cytosolic Ca2 oscilla-
tions is a result of Stx localization to early endosomes per se.
To this end, we performed the experiment at 18°C, a tem-
perature that leads to Stx accumulation in early endosomes
(Mallard et al., 1998). The histamine-induced Ca2 oscilla-
tions were not affected by a 20-min Stx incubation at this
temperature (Figure 5e), suggesting that the Stx-positive
endosomes must reach, and perhaps fuse with, another com-
partment to affect the cytosolic Ca2 oscillations caused by
histamine. We also wanted to investigate whether the effect
of Stx on oscillations in Ca2 levels is p38 dependent. Cells
were preincubated with SB203580 for 30 min before the
experiment was performed as described. Under these exper-
imental conditions, Stx treatment still inhibited the hista-
mine-induced Ca2 oscillations (Figure 5f), as seen without
the inhibitor (Figure 5d). Interestingly, the basal level of
cytosolic Ca2 was increased in the presence of SB203580
(Figure 5f). In summary, these data show that Stx is able to
act on Ca2 homeostasis by affecting the intracellular Ca2
cycling and that this is dependent on Stx internalization, but
not on p38 activity. Because the effects of holotoxin and
Figure 3. p38 inhibition protects against Stx,
but not ricin, cytotoxicity. HeLa cells were
treated with 30 M SB or carrier (DMSO; 0.1%
ﬁnal concentration) for 30 min (a and c) or
transfected with p38 siRNA1 or a control
siRNA 48 h before the experiment (b and d).
After this, the cells were incubated with in-
creasing concentrations of Stx (a and b) or
ricin (c and d) for 2.5 h. Protein synthesis was
measured by [3H]leucine incorporation. All
experiments were repeated at least twice with
duplicates. Error bars represent standard de-
viations.
Figure 4. StxB is able to activate p38 upon binding. (a) HeLa cells
were starved for 2 h in HEPES medium before incubation with 250
ng/ml StxB for the indicated times. Cells were lysed, and cell lysate
was passed through an anti-YP column. The eluate was then ana-
lyzed by Western immunoblotting with the indicated antibodies.
One percent of the WCL was analyzed by SDS-PAGE and Western
immunoblot to serve as control of equal loading on the column. (b)
HeLa cells were incubated with increasing concentrations of StxB
for 5 min at 37°C. Lysates were prepared and run for Western blot
analysis by using the indicated antibodies. These experiments were
repeated three times.
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puriﬁed B-chain were similar, one can use the B-chain alone
to investigate this phenomenon further.
Intracellular Trafﬁcking of Stx in HeLa Cells Is Sensitive
to Ca2 Levels: Nonadditive Effects of TMB-8 and p38
Inhibition
Cross talk between Ca2 signaling and p38 activation has
been proposed previously (Chao et al., 1992; Ikeda et al.,
2000; Takeda et al., 2004; Fazal et al., 2005), and we set out to
investigate whether there is a link between the requirements
for Ca2 and p38 in Stx transport. First, endocytosis assays
were performed in the presence of Ca2 chelators. As re-
ported by Chen et al. (2002), none of these chelators seemed
to affect Stx uptake to any large extent (data not shown).
However, we noticed that 1,2-bis(2-aminophenoxy)ethane-
N,N,N,N-tetraacetic acid (BAPTA)-AM, a membrane-per-
meant Ca2 chelator, became cytotoxic at concentrations
higher than 20 M (data not shown). We therefore tested the
effect of different concentrations on toxin sulfation. 20 M
BAPTA-AM reduced Stx sulfation by 80% compared with
that of the control (Figure 6a, black bars), whereas total
protein sulfation was reduced by 30% at this concentration
(Figure 6a, gray bars). The effect on total protein sulfation is
in agreement with the results of Chen et al. (2002) showing
that also anterograde, ER-to-Golgi, transport is sensitive to
removal of Ca2. In the further studies, we chose to work
with 10 M BAPTA-AM, a concentration that gave strong
reduction in Stx sulfation, but only moderately affected total
protein sulfation (Figure 6a). To conﬁrm these data, we
performed Stx toxicity experiments on cells treated with 10
M BAPTA-AM. Under these conditions, we observed a
15-fold protection against Stx (average  deviation, 14.8 
2.4; n  2) (Figure 6b).
We also investigated the Stx-induced activation of p38 in
the presence of BAPTA-AM. As shown in Figure 6c,
BAPTA-AM efﬁciently inhibited p38 phosphorylation.
To conﬁrm the results from experiments with BAPTA-
AM–treated cells, we also tested the effect of TMB-8, an
inhibitor of intracellular Ca2 release (Bencherif et al., 1995).
This inhibitor reduced Stx sulfation with 30% compared
with that of the control cells, whereas total protein sulfation
remained unaffected (Figure 6d). In agreement with this, we
observed a 2.5  1.1 (n  3) protection against Stx in cells
treated with TMB-8 (Figure 6e). Thus, these data indicate
that the cytosolic Ca2 level, and perhaps even a local
change in Ca2 concentration, is important for proper trans-
port of Stx to the Golgi apparatus.
Next, we wanted to study the link between Ca2 and the
requirement for active p38 for proper Stx transport. Because
inhibitors of both p38 and Ca2 release reduce Stx transport,
we reasoned that if p38 and Ca2 act on the same pathway,
cotreatment with the two inhibitors should not cause further
reduction. As shown in Figure 6f, no additive effect on Stx
sulfation was observed in cells treated with both SB203580
and TMB-8 compared with cells treated with SB203580
alone. This suggests that p38 activation and the level of Ca2
together regulate one step in the Stx transport.
HeLa cells were incubated at 18°C for measurements. Stx was added
as indicated. Histamine (1 M) was added 20 min after the Stx
addition. Traces presented are cut between 5 and 20 min. (f) Cells
were pretreated with 2 M SB203580 for 30 min. The cells were then
loaded with Fura-2AM. Stx was added 2 min after the measure-
ments started. Histamine (1 M) was added 15 min after the Stx
addition. Each trace is a representative Ca2 response for 18–30
individual cells per experimental condition.
Figure 5. Stx inhibits cytosolic Ca2 oscillations. Cytosolic Ca2
was measured in HeLa cells, loaded with the calcium probe Fura-
2AM. Stx (1 g/ml) was added to the medium, as indicated, after
initiation of Ca2 measurements. Histamine (1 M) was added 20 s
(a), 4 min (b), 10 min (c), or 15 min (d) after Stx addition. For c and
d, the traces are cut between 5 and 10 or 15 min, respectively. The
left traces represent cells without toxin. Traces show the Fura-2AM
ﬂuorescent ratio (340 nm/380 nm). (e) After Fura-2AM loading,
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Stx Regulates the Recruitment of p38 to Endocytic
Membranes in a Ca2-dependent Manner
In neurons, MAP kinase p38 has been shown to be targeted
to transport vesicles (Delcroix et al., 2003), and it has been
suggested to be implicated in regulation of neurotransmitter
transport. We therefore tested whether Stx binding was able
to regulate the targeting of p38 to endosomes. To facilitate
the studies, we used HEp2 cells, which, in contrast to HeLa
cells, contain vesicles easily separable in a sucrose gradient.
As a control, HEp2 cells were tested in Stx sulfation exper-
iments in the presence of p38 siRNA (Supplemental Figure
S3A) and SB203580 or TMB-8 (Supplemental Figure S3B),
and they were shown to respond as HeLa cells. Cellular
fractions were puriﬁed as described previously (Aniento et
al., 1996). Equal amounts of the puriﬁed endosomal fractions
were analyzed by SDS-PAGE and Western immunoblot.
p38was found in the early endosomal fraction, and recruit-
ment to this fraction occurred in an Stx-dependent manner
(Figure 7a). In agreement with this ﬁnding, we observed
increased vesicular p38 staining pattern in HeLa cells treated
with Stx, compared with control cells, as shown by immu-
noﬂuorescence microscopy (Figure 7b). And, indeed, a frac-
tion of the Stx-positive endosomes were positive for p38
(Figure 7b) and the early endosome marker EEA1 (Supple-
mental Figure S4). Importantly, we did not observe translo-
cation of p38 to the nucleus upon Stx stimulation, suggesting
a local activation of p38 on endosomes (see Discussion).
To test a possible inﬂuence of variations in Ca2 levels on
p38 recruitment to endosomes, we repeated the endosome
puriﬁcation in the presence of TMB-8. As shown in Figure
7c, this inhibitor blocked p38 recruitment to early endoso-
mal membranes (top, compare lanes 5 and 11). In agreement
Figure 6. StxB transport to the TGN is sensitive to Ca2 variations. (a) HeLa cells were incubated with BAPTA-AM at the indicated
concentrations or the carrier (DMSO; 0.1% ﬁnal concentration) for 30 min before incubation with StxB for 45 min and lysis of the cells. StxB
was immunoprecipitated from the lysates, and its degree of sulfation analyzed by SDS-PAGE and autoradiography. The band intensities were
calculated and plotted as average of parallels. Total cellular proteins sulfation was measured after TCA precipitation and plotted relative to
the control. This experiment was performed twice with duplicates; error bars show deviations. (b) Cells were incubated with or without 10
M BAPTA-AM for 30 min before addition of Stx. The experiment was then performed as described in Figure 3. This experiment was
performed twice with duplicates; error bars show deviations. (c) Cells were serum starved for 1 h, and then they were treated with or without
10 M BAPTA-AM for 30 min before StxB was added. Cell lysates were separated by SDS-PAGE and analyzed by Western blot.
Quantiﬁcation of three separate experiments is shown in the histogram. (d) Cells were incubated with 100 M TMB-8 or the carrier (DMSO;
0.1% ﬁnal concentration) for 30 min before incubation with StxB-Sulf2 for 45 min. The experiment was then carried out as described in A. (e)
Cells were incubated with or without 100 M TMB-8 for 30 min before addition of Stx. The experiment was then performed as described in
Figure 3. This experiment was repeated three times with duplicates. Error bars show deviations. (f) As in d, but in this assay cells were also
treated or not with 30 M SB203580 before addition of StxB-Sulf2. This experiment was repeated twice with duplicates. Error bars show
deviations.
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with previous studies (Cavalli et al., 2001), the early endo-
somal marker Rab5a was redistributed upon p38 activation
(Figure 7c). Rab5a was also sensitive to Ca2 depletion
(Figure 7c). We therefore used annexin II as an additional
internal marker (Figure 7c), because it has been shown to be
only partially sensitive to Ca2 depletion (Jost et al., 1997;
Konig and Gerke, 2000). Despite the fact that a fraction of
annexin II was detached from the endosomes upon TMB-8
treatment, the protein did not seem to be sensitive to Stx
binding, and it could therefore be used as a marker for the
stability of our system in respect to Stx. Finally, we used
GM130 as a marker for Golgi membranes to show the purity
of our endosome fractions (Figure 7c). These data suggest
that the Ca2 requirement for endosome to Golgi transport
of Stx can be connected to the Ca2 dependent recruitment
of p38 to endosomes. Furthermore, the ability of the toxin to
promote this recruitment may be related to the Stx-depen-
dent modiﬁcation of Ca2 ﬂuxes.
DISCUSSION
We have previously shown that Stx is an active player in
mediating its own transport. Stx activates the tyrosine kinase
Syk, which then speciﬁcally regulates cell entry of the toxin
(Lauvrak et al., 2006). In the present article, we elucidate
further on the ability of Stx to promote its own transport. We
show that endosome to Golgi transport of Stx is regulated by
the MAP kinase p38 and Ca2. Endocytosis of Stx induces a
change in cytosolic Ca2 levels, which in turn leads to
activation of p38 and its recruitment to early endosomes.
The role of p38 in endosome to Golgi transport has not
previously been investigated, but p38 has been found to
regulate endocytosis and transport from endosomes. Fratti
et al. (2003) have demonstrated that the activation of p38 by
Mycobacterium tuberculosis is important for correct sorting of
the pathogen (Fratti et al., 2003), and -amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor trafﬁcking is im-
proved by p38 (Huang et al., 2004). More recently, p38 has
been implicated in the endocytosis of  opioid receptor
(Mace et al., 2005), and together with p38, in epidermal
growth factor receptor internalization (Vergarajauregui et
al., 2006).
In the present study, inhibition of p38 activity, or knock-
down of p38, impaired transport of Stx from endosomes to
the Golgi apparatus and protected the cells against the toxin.
Importantly, the phenotypes observed by the two different
methods used to validate the implication of p38 in intra-
cellular trafﬁcking of Stx, were similar, even though the
incubation times differed signiﬁcantly for the chemical in-
hibitors and siRNA. The requirement for p38 in retrograde
transport seems to be speciﬁc for Stx, because there was no
effect on transport of the related toxin ricin upon inhibition
of p38 activity. These data are in agreement with the ﬁnd-
ings that p38 regulates sorting from early endosomes by
phosphorylation of Rab5-GDI, EEA1, and Rabenosyn-5
(Cavalli et al., 2001; Fratti et al., 2003; Huang et al., 2004; Mace
et al., 2005). It was recently suggested that Stx retrograde
transport is independent of Rab5 (Fuchs et al., 2007). Future
studies are needed to clarify these questions.
Previous reports show that p38 inhibitors protect different
cell lines against Stx (Ikeda et al., 2000; Smith et al., 2003;
Stricklett et al., 2005). However, these were studies of apo-
ptotic cell death after long-term incubation with the toxin (24
h), and p38 activation was in these cells (Vero and brain
endothelial cells) a late event induced by entry of active
A-chain into cytosol. In contrast, we show that Stx rapidly
activates p38 in HeLa cells. Also, as shown, after only 2.5 h
of incubation with the toxin, there is a strong decrease in
Stx-induced toxicity in cells treated with p38 inhibitor. A
similar protection could be observed even after 90 min (data
not shown). The strong protection might be due to a com-
bination of two effects, the p38-dependent trafﬁcking de-
scribed in the present article, and ribotoxic stress attenuation
described in previous reports (Foster and Tesh, 2002; Smith
et al., 2003). Nevertheless, ricin, which also triggers ribotoxic
stress (Iordanov et al., 1997; Foster and Tesh, 2002), was not
affected by p38 inhibition, suggesting that Stx-related p38
activity is mainly dedicated to Stx trafﬁcking in HeLa cells.
The strong effect on Stx toxicity after p38 inhibition may
indicate that p38 regulates transport from the Golgi appara-
tus to the ER as well. It would, therefore, be interesting to
test whether p38 is also recruited to the Golgi membrane
upon Stx binding.
The importance of Ca2 homeostasis for Stx transport has
been demonstrated, but signaling proteins linked to this
Ca2 requirement have not previously been characterized
(Sandvig and Brown, 1987; Ikeda et al., 2000; Chen et al.,
2002). Here, we have shown that Stx is able to trigger
changes in Ca2 levels induced by ATP or histamine. This
effect was not observed under conditions where Stx was
retained in the early endosomes, suggesting that endosome
Figure 7. p38 is recruited to early endosomes by a Ca2-dependent
mechanism upon Stx binding. (a) HEp2 cells were starved for 1 h
before incubation with 250 ng/ml StxB for 20 min. Endosome frac-
tions were prepared as described in Materials and Methods, and equal
amounts of proteins were separated by SDS-PAGE and analyzed by
Western immunoblotting with the indicated antibodies. (b) HeLa
cells were incubated with 2 g/ml StxB for 0 (top) or 20 min
(bottom) before ﬁxation and permeabilization. Antibodies against
p38 and Stx were used. Bar, 5 m. (c) As in a, but cells were treated
with or without TMB-8 for 30 min before stimulation with 250
ng/ml StxB. Equal amounts of all fractions were separated by
SDS-PAGE and analyzed by Western blot.
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fusion with a later compartment might be required for the
Stx-induced change in histamine-induced cytosolic Ca2 os-
cillations. However, this ﬁnding does not exclude that Stx is
able to induce Ca2 changes in proximity to endosomes
without fusion to another compartment, and with different
kinetics. We further show that modiﬁcation in Ca2 levels is
necessary for activation of p38 and its recruitment to early
endosomes after Stx stimulation. p38 inhibition did not affect
the Stx-induced change in Ca2 oscillations, supporting that
p38 activation and recruitment to endosomes may occur
after Ca2 signaling.
We have presented data showing that there is a link
between Ca2, p38 and Stx trafﬁcking on the endosomal
level. MAP kinases were reported to be found on endosomes
even before any connection to trafﬁcking was demonstrated
(Pol et al., 1998). In our assay, we observed that a small
fraction of p38 is activated upon Stx binding, suggesting that
a small pool of p38 is sufﬁcient to regulate toxin transport.
One can speculate that this pool has to be targeted to the
endosomal membrane in order to regulate Stx trafﬁcking. In
other words, in contrast to EGF receptor internalization
(Vergarajauregui et al., 2006; Zwang and Yarden, 2006), ac-
tivation of p38 in itself may not be sufﬁcient to improve Stx
trafﬁcking. The endosomal recruitment is likely to be depen-
dent on the presence of scaffold proteins (Morrison and
Davis, 2003; Kolch, 2005). Such proteins have been shown to
be essential for the recruitment of extracellular signal-regu-
lated kinase to the Golgi (Morrison and Davis, 2003; Wang et
al., 2005) or to the late endosome/lysosome (Wunderlich et
al., 2001; Teis et al., 2002). It was recently shown that p38
requires -arrestin-1 recruitment for proper activation in
platelet-activating factor-stimulated cells (McLaughlin et al.,
2006). For the present story, it is, therefore, tempting to
speculate on the existence of a Ca2-dependent scaffolding
protein that is involved in recruitment of p38 to endosomes.
Interestingly, it has been shown that scaffold proteins can be
sufﬁcient to activate p38 (Ge et al., 2002), suggesting that
the proper targeting can bypass an upstream signaling cas-
cade. Together, these results support a critical role for a yet
unidentiﬁed scaffold protein that would link p38 to endo-
somes in a Ca2-dependent manner.
In previous studies, we have observed that compensatory
trafﬁcking events can take place upon inhibition or knock-
down of proteins essential for trafﬁcking (Llorente et al.,
2003; Utskarpen et al., 2006). For p38, there were no indica-
tions of such, supporting that this kinase has a unique role in
the endosome to Golgi and ER route of Stx. Thus, in contrast
to the reduced Stx transport after Rab6A inhibition, which
can be overcome by upregulation of Rab6A’ (Del Nery et al.,
2006; Utskarpen et al., 2006), there is an absolute requirement
for p38 activity for proper trafﬁcking of Stx.
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